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Association between alcohol consumption
during pregnancy and risks of congenital
heart defects in offspring: meta-analysis of
epidemiological observational studies
Zhongyuan Wen1†, Di Yu1†, Weiyan Zhang1, Changfeng Fan1, Liang Hu1, Yu Feng1, Lei Yang1, Zeyu Wu1,
Runsen Chen1, Ke-jie Yin2 and Xuming Mo1*
Abstract
Background: To explore the association between maternal alcohol consumption and/or binge drinking and congenital
heart defects (CHDs), we conducted a meta-analysis for more sufficient evidence on this issue.
Methods: We searched Medline, EMBASE, and the Cochrane Library from their inceptions to December 2014 for
case-control and cohort studies that assessed the association between maternal alcohol consumption and CHD
risk. Study-specific relative risk estimates were calculated using random-effect or fixed-effect models.
Results: A total of 19 case-control studies and 4 cohort studies were included in the meta-analysis. We observed
a null association between maternal alcohol consumption during pregnancy and the risk of CHDs. Even in the analysis
of different trimesters of pregnancy, we found little association between the two.
Conclusions: This meta-analysis suggests that maternal alcohol consumption is modestly not associated with the risk
of CHDs. However, further investigation is needed to confirm this conclusion.
Keywords: Congenital heart defects, Alcohol drinking, Pregnancy, Meta-analysis
Background
Congenital heart defects (CHDs) are the most common
group of congenital malformations, affecting nearly 1 %
of live births throughout the world [1]. CHDs account
for approximately one-third of all congenital anomalies
and are the leading noninfectious cause of death in the
first year of life [2]. Although massive breakthroughs
have been achieved in cardiovascular diagnostics and
cardiothoracic surgery over the past century, leading to
the increased survival of newborns with CHDs, the eti-
ology of most congenital heart defects is still unknown.
A number of chromosomal anomalies, certain mater-
nal illnesses, and prenatal exposures to specific thera-
peutic drugs are recognized risk factors. It is difficult to
establish the role of a single factor because in many
cases, the cause of a defect is believed to be multifactor-
ial, including environmental teratogens with genetic and
chromosomal conditions [3]. Maternal alcohol consump-
tion is associated with a variety of harmful effects to the
fetus, as demonstrated by the range of impairments
present in fetal alcohol syndrome [4]. Various clinical
signs have been described, which led to the classification
of different degrees of embryopathy, ranging from pa-
tients with minor symptoms, the so-called “alcohol
effects”, to the most severely affected individuals [5]. Up
to one-third of affected individuals have congenital car-
diac disease [6].
A study by Jones et al. [7] was one of the first to report
the association between maternal alcohol consumption
and CHDs. However, the evidence since then has been
mixed, with some studies showing positive associations
and others providing null results. CHDs include distinct
subtypes (e.g., conotruncal defects, left ventricular outflow
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track defects, septal defects), and there is potential for
etiologic heterogeneity. Binge drinking is defined as con-
suming ≥5 alcoholic drinks at one sitting [8].
Because the matter of whether there is an association
between maternal alcohol consumption and/or binge
drinking and congenital heart defects remains uncertain,
we conducted this meta-analysis for more sufficient evi-
dence on this issue.
Methods
A computerized literature search was conducted in MED-
LINE, EMBASE, and the Cochrane Library from their in-
ceptions to December 1, 2014, by two independent
investigators (Wen and Yu). We searched relevant studies
using the following medical subject heading terms and/or
text words: “congenital heart defect”, “heart abnormal-
ities”, “CHD”, and “heart malformation” in combination
with “alcohol”, “drinking”, “maternal alcohol consump-
tion”, “maternal drinking”, “periconceptional drinking”,
and “binge drinking”. In addition, we performed a broader
search on environmental teratogens and CHDs and
checked the reference lists of retrieved articles and rele-
vant review articles to identify additional relevant studies.
Eligibility criteria
We selected articles that (1) were original epidemiologic
studies (i.e., case-control, cohort), (2) were published in
the English language, (3) examined the association be-
tween maternal alcohol consumption any time during
pregnancy and CHDs overall or any one of the CHD
subtypes in infants, (4) reported relative risk or odds ra-
tios (RRs or ORs) and associated 95 % confidence inter-
vals (CIs) or had raw data available, (5) defined CHDs or
one of the CHD subtypes as an outcome, and (6) provided
exposure information. If the articles were duplicated or
were from the same study population, the article with a
larger sample size was included. Non-peer-reviewed arti-
cles, ecologic assessments, correlation studies, experimen-
tal animal studies and mechanistic studies were excluded.
Data extraction
One study author (Wen) first screened studies by title
and abstract and made exclusions based on the eligibility
criteria. The studies that met the inclusion criteria were
independently reviewed by two authors (Wen and Yu) to
retrieve the information of interest including study char-
acteristics (i.e., authors, year of publication, geographic
region, periods of data collection, study design, case
classification, control definition, sample size, source of
exposure data, drinking status, levels of drinking, expos-
ure period during pregnancy, and adjusted/matched var-
iables) and to record reported effect estimates and
associated 95 % CIs as well as raw data if effect estimates
were not available. Discrepancies between the authors
were resolved by discussion.
The corresponding risk estimates (including RRs and
ORs) and 95 % CIs were extracted from each study for
CHDs overall, CHD subtypes and the period of maternal
alcohol consumption during pregnancy. We selected the
main confounder-adjusted RRs or ORs whenever pos-
sible. Otherwise, unadjusted effect estimates were ex-
tracted from each study. We conducted meta-analyses
for specific CHD subtypes (i.e., sub-analyses) if at least
two studies had available data. The RRs were used as
the common measure of association across studies.
ORs were transformed into RRs according to the for-
mula RR = OR/[(1-P0) + (P0 × OR)] where P0 stands for
the incidence of CHDs [9]. Because of the low inci-
dence of CHDs, ORs could be considered as RRs.
Statistical analysis
Statistical analysis was based on comparing the highest
alcohol consumption and binge drinking with the lowest
consumption (which could have included women who
did not drink). We calculated summary RR estimates
and 95 % CIs using both fixed- and random-effects
models for CHDs overall and for the CHD subtypes.
We first tested for heterogeneity across studies using
Cochran Q and I2 statistics [10]. If there was evidence of
heterogeneity (P < 0.05 or I 2≧ 50 %), we used a random-
effects model, which provided a more appropriate sum-
mary effect estimate between heterogeneous study-specific
estimates. If the Cochran Q and I2 statistics showed no evi-
dence of heterogeneity, we used a fixed-effects analysis,
applying inverse variance weighting to calculate summary
RR estimates [11].
Meta-analyses of total maternal alcohol consumption
and binge drinking were both included. Subgroup analysis
of CHDs was conducted by CHD subtype (e.g., conotrun-
cal defects, left ventricular outflow track defects, septal
defects), study design (cohort and case-control studies),
geographic region (Europe and America) and study adjust-
ments (smoking, maternal age and ethnicity). In the main
analyses that examined the association between maternal
alcohol consumption and the risk of CHDs overall, we cal-
culated a summary effect estimate for CHDs overall lim-
ited to the studies that examined the association between
maternal periconceptional drinking (i.e., 3 months before
pregnancy through the first trimester) and CHDs.
Publication bias was evaluated by generating funnel plots
for a visual examination, conducting correlation and regres-
sion tests for significance, and using Egger’s linear regres-
sion [12] and Begg’s rank correlation [13] methods. A
P value of <0.05 for the two aforementioned tests was con-
sidered representative of significant statistical publication
bias. All statistical analyses were performed using STATA
(version 11.0; StataCorp, College Station, Texas, USA).
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Results
Literature search
The search strategy generated 4181 citations, of which
23 were identified in the final analysis (Fig. 1). All of
the studies were published from 1989 to 2014. There
were 19 case-control studies [14–32] and 4 cohort
studies [33–36].
Study characteristics
The main characteristics of the included studies are shown
in Table 1. As is shown, 13 studies [15–20, 24, 25, 27, 28,
30–32] were conducted in the United States, 7 in Europe
[14, 21–23, 26, 29, 34], and 3 in other regions (Canada and
Australia) [33, 35, 36]. A wide range of exposure periods
was examined, with 10 studies reporting the mother’s
drinking or binge drinking during the first trimester of
pregnancy, including 1 to 3 months before conception
[14, 17–19, 24, 25, 27, 28, 31, 33]; however, 13 studies
did not specify the months of exposure during preg-
nancy. Additionally, 5 studies provided estimates on the
association between maternal alcohol consumption and
CHDs adjusted for a range of covariates (e.g., smoking, cof-
fee consumption, maternal age, ethnicity, education, occu-
pation) [17, 19, 33, 34, 36], and 18 studies reported only
unadjusted estimates (Table 1). The studies derived their
cases from various birth defect registries [18–23, 29, 35],
and the control subjects were randomly selected from birth
certificates or hospital records or matched to cases by birth
region or birth month [16, 18]. For some studies, cases
were derived from a sample of live-born infants, whereas
for other studies, cases were also identified from stillbirths,
neonatal deaths, and elective terminations.
Maternal alcohol consumption and CHDs
Overall, 23 studies evaluated the association between ma-
ternal alcohol consumption during pregnancy and CHDs as
a group in a total of 19,160 CHD cases (Table 1). We found
that maternal alcohol consumption may have no associ-
ation with an increased risk of CHDs (RR =1.11, 95 % CI =
0.96–1.29) (Fig. 2). The results were consistent with the
overall summary measure when the analyses were restricted
to case-control studies (RR = 1.00, 95 % CI = 0.95-1.06) or
cohort studies (RR = 1.35, 95 % CI = 0.93-1.97). When we
turned to the period of maternal alcohol consumption dur-
ing pregnancy, the statistics showed that maternal drinking
during different times of pregnancy had no impact on the
incidence of CHDs. Specifically, 6 studies focused on
women who drank during pre-pregnancy and confirmed
that no association was found between maternal drinking
and CHD risk (RR = 0.95, 95 % CI = 0.88–1.04) (Table 2).
Another 22 studies also looked at women who drank
during pregnancy, but no results showed that maternal
drinking during pregnancy was associated with CHDs
(RR = 1.12, 95 % CI = 0.96–1.30) (Table 2). Additionally,
Egger’s test (P = 0.156) showed no evidence of publica-
tion bias for the period of maternal alcohol consump-
tion during pregnancy. In the subgroup analyses by
geographic region, we observed null results among both
European (RR = 1.09, 95 % CI = 0.99–1.19) and North
American (RR = 1.10, 95 % CI = 0.89–1.36) populations.
In the adjustment models, we chose smoking as im-
portant, but unfortunately, a null result was found for
smoking (RR = 1.284, 95 % CI = 0.817–2.016). Eight other
studies were about the dose-response data on maternal al-
cohol consumption and risk of CHDs. It showed that with
the increase of alcohol consumption, the corresponding
risk of CHDs did not increase (Fig. 3). Most of these re-
sults showed that the amount of maternal drinking was
not associated with CHDs except in 2 studies: Martinez-
Frias’s research reported that women who drank more
than 116 grams a day possibly had a 1093 % increased
risk of CHDs (RR = 11.93, 95 % CI = 1.62–246.00), and
Williams’ report showed that maternal alcohol con-
sumption of more than 22 grams per day was associ-
ated with a 213 % increased risk of CHDs (RR = 3.13,
95 % CI =1.19–8.22) (Table 3).
Discussion
To our knowledge, this is the first meta-analysis to report
on the association between maternal alcohol consumption
and CHDs. Although the studies included in our analysis
varied in terms of case definition, control selection, and
exposure assessment, the associations were largely consist-
ent in the sub-analyses. Our findings indicated that mater-
nal alcohol consumption during pregnancy might have no
association with the risk of CHDs. Additionally, statisti-
cally significant heterogeneity was detected (Q = 46.52,
Fig. 1 Study selection procedures. Study selection procedures for a
meta-analysis of alcohol consumption during pregnancy and the risk
of congenital heart defects (CHDs) in offspring
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Table 1 Summary of the studies included in the meta-analysis
First author, year Region Period Study design No. of cases/controlsa period OR/RR 95 % CI Adjustment variablesb Outcome
Bean, 2011 USA 2001–2004 CC 566/552 1st month gestation 1.07 0.58–1.98 No AVSD
1.03 0.48–2.23 ASD
0.49 0.19–1.22 VSD
2nd/ 3rd month gestation 0.64 0.19–2.21 AVSD
1.50 0.40–5.67 ASD
1.08 0.27–4.36 VSD
Botto, 2000 USA 1968–1980 CC 958/3029 During pregnancy 1.00 0.86–1.15 No CHDs
Carmichael, 2003 USA 1987–1988 CC 207/481 1 month before to 3rd month gestation 1.35 0.84–2.19 B, D, F, K, I TGA
1.24 0.77–1.98 TOF
Cedergren, 2002 Sweden 1982–1996 CC 269/524 Early pregnancy 0.95 0.69–1.31 No CHDs
Ewing, 1997 USA 1981–1989 CC 641/3549 During pregnancy 0.95 0.78–1.15 No VSD
Fixler, 1998 USA CC 89/82 3 months before to 3rd month gestation 1.23 0.67–2.28 No CHDs
Grewal, 2008 USA 1999–2003 CC 323/700 During pregnancy 1.21 0.85–1.73 No Conotruncal defects
Hobbs, 2010 USA 1998–2006 CC 572/363 1 month before to 3rd month gestation 0.84 0.63–1.12 No CHDs
Kuciene, 2009 Lithuania 1999–2005 CC 187/643 During pregnancy 1.39 0.87–2.25 No CHDs
Larsen, 2011 Denmark 1996–2002 Cohort 477/ 86783 During pregnancy 1.24 0.97–1.59 A, E, F, H, P VSD
0.89 0.66–1.21 ASD
Liu, 2013 Canada 2002–2010 Cohort 4123/22365 During pregnancy 1.88 1.74–2.04 A, B, E, F, H, L, O CHDs
McDonald, 1992 Canada 1982–1984 Cohort 318/87389 First trimester 0.96 0.78–1.19 A, B, D, F, G CHD
Malik, 2008 USA 1997–2002 CC 3067/3947 1 month before to 3rd month gestation 0.93 0.85–1.03 O CHDs
Martinez-Frias, 2004 Spain CC 4705/4329 During pregnancy 0.96 0.78–1.19 No CHD
Mateja, 2012 USA 1996–2005 CC 237/948 3 months before pregnancy 1.01 0.61–1.70 No CHDs
O’Leary, 2013 Australia. 1983–2007 Cohort 277/61370 During pregnancy 1.40 0.91–1.98 No VSD
2.86 1.22–4.93 ASD
2.01 0.58–4.07 Conotruncal defects
Smedts, 2009 Netherlands 2008 CC 276/324 During pregnancy 1.05 0.75–1.47 No CHDs
Steinberger, 2002 USA 1981–1989 CC 237/3572 During pregnancy 1.00 0.10–7.70 No Single Ventricle












Table 1 Summary of the studies included in the meta-analysis (Continued)





Van Beynum, 2010 Netherlands 1996–2005 CC 611/2401 During pregnancy 1.05 0.85–1.29 No CHDs
Williams, 2004 USA 1968–1980 CC 122/3029 3 months before to 3rd month gestation 1.02 0.71–1.47 No VSD
Yauck, 2004 USA 1997–1999 CC 245/2780 During pregnancy 2.10 1.10–4.20 No CHDs
CC case-control study, CHDs congenital heart defects, VSD Ventriculap Septal Defect, ASD Atrial Septal Defect, TOF Tetralogy of Fallot, TGA D-Transposition of the Great Arteries, HLHS Hypoplastic Left Heart Syndrome,
COA Coarctation of the Aorta, AVSD Atrioventricular Septal Defect
aReported number of cases and control subjects with available exposure information
bAdjustment variables: A maternal age, B maternal race/ethnicity, C marital status, D maternal education, E parity, F smoking, G coffee consumption, H infant’s year/month of birth, I intake of multivitamin,












Table 2 Summary risk estimates of the association between maternal alcohol comsuption and CHD risk in offspring
Subgroup analysis No. of studies Summary RR (95 % CIs) P* I2 (%) P**
Summary pooled estimate 23 1.11(0.96–1.29) <0.001 88.8
Design 0.025
Case-control 19 1.00(0.95–1.06) 0.260 16.0
Cohort 4 1.35(0.93–1.97) <0.001 94.4
Geographical region 0.447
North America 15 1.10(0.89–1.36) <0.001 92.1
Europe 7 1.09(0.99–1.19) 0.449 0.0
Australia 1 1.69(1.23–2.33) - -
Period of pregnancy 0.343
Pre-pregnancy or until pregnancy is known 6 0.95(0.88–1.04) 0.426 0.0
During pregnancy 22 1.12(0.96–1.30) <0.001 89.3
Trimester 1 22 1.12(0.96–1.30) <0.001 89.3
Trimester 2 12 1.22(0.98–1.52) <0.001 90.9
Trimester 3 12 1.22(0.98–1.52) <0.001 90.9
Adjusted for smoking 0.108
Yes 4 1.27(0.86–1.87) <0.001 94.6
No 19 1.04(0.96–1.13) 0.042 39.0
Abbreviations: RR relative risk, CI confidence interval
*p-value for heterogeneity within each subgroup
**p-value for heterogeneity between subgroups with meta-regression analysis
Fig. 2 Pooled Relative risk (RR). RR estimates for the association between maternal alcohol consumption and the risk of CHDs. Meta-analysis random
effects estimates were used. The sizes of the squares reflect the weighting of the included studies. Bars represent 95 % confidence intervals (CIs).
The center of the diamond indicates the summary effect; the left and right points of the diamond indicate the 95 % confidence interval
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P < 0.001, I2 = 88.8 %), although no publication bias was
indicated from Egger’s test (P = 0.156) while Begg’s test
(P = 0.037) indicated a publication bias (Fig. 4). Because
of the existence of heterogeneity, the power of Begg’s
test lowed. Therefore we conducted the subgroup ana-
lyses and meta-regression analyses (Table 2). In the sub-
analyses of design types, geographical region, period of
pregnancy and adjusted for smoking, the results were al-
most consistent with the pooled RR. Meta-regression ana-
lysis showed that the different study design might result in
the heterogeneity. Moreover, when findings were stratified
by geographic reign, null results were found among
American and European populations, although a rate of
69 % was found among Australian populations. However,
the study on Australian populations was conducted in
only one paper by one author [31], and there were 277
cases from 1983–2007 in his report. He observed positive
associations between maternal alcohol consumption
during pregnancy and the CHD subtypes he analyzed:
Ventricular septal defect (VSD) (RR = 1.36, 95 % CI =
1.14–1.63) and Atrial septal defect (ASD) (RR = 1.77,
95 % CI = 1.27–2.46); conotruncal defects (RR = 1.50,
95 % CI = 0.98–2.30). O’Leary attempted to demon-
strate that maternal drinking was associated with differ-
ent types of CHDs, but the number of ASD cases he
found was 60, only 0.3 % of the exposed group, and the
rate of conotruncal defects was 0.1 % as well. A smaller
sample size could be why this result differed from
others. However, there is another possibility that is
worth our attention. The differences between the
American, European and Australian natures of alcohol
consumption could also have caused these effects. As
we know, different wine has different components. For
example, beer is made from wheat and Humulus lupu-
lus, whisky is mainly made from Hordeum vulgare,
brandy is made from fruits such as grapes, and so on.
Criqul MH found the so-called “French Paradox”, that
the French have a relatively low incidence of coronary
heart disease while having a diet that is relatively rich
in saturated fats [37]. He indicated that wine made
from grapes could be the primary explanation for the
phenomenon. However, we found very few statistics re-
garding the ingredients of different wine, and from our
point of view, this question deserves to be studied in
the future. Among those statistics that found that ma-
ternal alcohol consumption had a positive association
with CHD risk, Martinez-Frias reported that consump-
tion of more than 116 grams per day could increase
CHD risk [29]. We must here highlight that this study
had only 67 cases and 20 controls, which is quite small
compared with the other sample sizes, and this authors
report also had no adjustment variables; this dose of al-
cohol consumption could lead to a number of diseases
that could have an impact on CHD risk. The Williams
study had the same problem as well. Based on the ad-
justment results, the potentially important confounding
factor of smoking was excluded in the analysis of alcohol
consumption. However, there was no association between
maternal alcohol consumption and CHDs following ad-
justment for smoking, indicating that smoking has little
influence on CHDs. However, Lee et al. [38] confirmed
the association between maternal smoking and increased
risk of CHDs by meta-analysis. The influence of maternal
smoking on CHD risk needs further study.
The result of our meta-analysis is in reality rather con-
fusing. As we all know, alcohol consumption has a num-
ber of effects on our health. However, our research
shows that maternal alcohol consumption during preg-
nancy may have no association with the risk of CHDs.
Ethyl alcohol as the main component of wine has been
suggested to play a positive role in heart disease. We
speculate that a small amount of alcohol may have little
influence in increasing the risk of CHDs. However, these
statistics do not intend to say that maternal drinking is
safe; the fact is that even low levels of prenatal alcohol
exposure, such as in a single dose, can produce the birth
defect termed fetal alcohol syndrome (FAS), and as
many as 54 % of live-born children with FAS present
with some form of cardiac anomalies [39], e.g., septal de-
fects and pulmonary stenosis [20], that can lead to de-
velopmental challenges, ongoing medical care and death.
Additionally, findings have shown that alcohol consump-
tion during pregnancy may affect the Wnt/β-catenin sig-
naling that allows for normal gene activation and
cardiogenesis [40].
Our study has a number of strengths, including the
large sample (n = 19,160) used to estimate the effect of
maternal alcohol consumption on CHDs as a group. Add-
itionally, because the suspected heterogeneous etiologies
Fig. 3 The dose-response of relative risk and alcohol intake: The
dose-response of relative risk and alcohol intake: the corresponding
risk of CHDs did not increase with the increase of alcohol consumption.
The full line indicates the relative risk of CHDs along with the alcohol
intake (grams/day); the dashed lines indicate the 95 % confidence interval
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Table 3 Characteristics of 8 observational studies with dose-response data on maternal alcohol consumption and risk of CHDs




OR/RR 95 % CI Adjustment variablesc Outcome
Carmichael, 2003 USA 1987–1988 CC 207/481 1 month before to 3rd month gestation 0 1.00 1.00–1.00 B, D, F, K, I Conotruncal defects
0.9 1.20 0.80–1.70
3 1.60 0.80–3.00

































Table 3 Characteristics of 8 observational studies with dose-response data on maternal alcohol consumption and risk of CHDs (Continued)








CC case-control study, CHDs congenital heart defects, VSD Ventriculap Septal Defect, ASD Atrial Septal Defect, TOF Tetralogy of Fallot, TGA D-Transposition of the Great Arteries, HLHS Hypoplastic Left Heart Syndrome,
COA Coarctation of the Aorta, AVSD Atrioventricular Septal Defect
aReported number of cases and control subjects with available exposure information
bConverted into pure ethanol in grams from the original data
cAdjustment variables: A maternal age, B maternal race/ethnicity, C marital status, D maternal education, E parity, F smoking, G coffee consumption, H infant’s year/month of birth, I intake of multivitamin, J stress, K
folic acid intake/dietary folate, L infant gender, M maternal body mass index, N family history of congenital heart defects, O maternal residence, P maternal occupation, Q insurance, R cases and controls matched on












can affect CHD risk during different times in pregnancy,
we divided pregnancy into stages; still, no association was
found in any of the stages. However, our study must also
be considered in light of certain limitations. First, our ana-
lysis is limited to studies published in English. Evidence of
publication bias was found, and there was heterogeneity
in the component studies, which could have been attribut-
able to study design, study populations, analytic strategies
or other unknown factors. Second, we derived most of our
data from case-control studies, which may be more prone
to information bias than cohort studies. Third, the con-
sumption quantity in each study varied, including times/
week, drinks/week, drinks/occasion, etc. The highest and
lowest intakes varied across studies, and the highest intake
in one study could have been similar to the median or low-
est intake in another, which could have biased the overall
results. Additionally, based on the different methods that
were used to assess and report alcohol consumption across
studies, we established the dose-response relationship
between alcohol consumption and CHDs. It showed that
the risk of CHDs did not influence with the increase of al-
cohol consumption, even binge drinking. Fourth, because
of our inability to fully adjust for various confounders, as-
sociations between alcohol consumption and CHDs could
be attributed to other factors, such as maternal smoking,
ethnicity, age, and education. Fifth, our analysis included a
wide range of exposure periods, but heart anomalies de-
velop during weeks 2–7 of gestation [41]. We suspect that
our including studies that assessed exposure beyond the
critical period may have biased our result toward the null.
That is, the summary results may be a misestimate of the
relative risk of CHDs associated with alcohol consumption.
Conclusions
In conclusion, our analysis indicates that maternal alcohol
consumption has no association with CHD risk. However,
the findings from our study need to be confirmed in fu-
ture research in well-designed cohort or intervention
studies. In addition, the underlying mechanisms call for
further elucidation.
Although its effects are modest, drinking is relatively
common among women of reproductive age and could
have important public health consequences. Young
women continue to drink although the adverse effects of
drinking on reproductive health are known, and some
women continue to drink even after they learn that they
are pregnant. Decreased maternal alcohol consumption
during pregnancy would result in improved reproductive
outcomes and could contribute to reduced infant mor-
tality and morbidity.
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